Skip to main content
Clinical Trials/NCT04465006
NCT04465006CompletedNot Applicable

Efficacy of Hippotherapy Simulator Exercise Program in Stroke Patients

Marmara University2 sites in 2 countries26 target enrollmentStarted: December 1, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
26
Locations
2
Primary Endpoint
Rivermead Mobility Index

Study Overview

Brief Summary

The aim of our study is to investigate the effects of hippotherapy simulator exercises in addition to the conventional rehabilitation program on the balance, postural control, mobility, functional capacity, and independence levels of stroke patients.

Detailed Description

Twenty-six 18- 65 years of patients with stroke were included in the study. Patients were divided into two groups as hippotherapy simulator group (HSG) (n = 13) and conventional exercise group (CEG) (n = 13). Patients were evaluated with Berg Balance Scale (BBS) for balance, Postural Assessment Scale for Stroke (PASS) for postural control, Rivermead Mobility Index (RMI), and Time Up- Go Test (TUG) for mobility, 2min. Walking Test (2mWT) for functional capacity and Barthel Index (BI) for the level of independence respectively before and after treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Getting a diagnosis of stroke by a specialist physician,
  • Being between the ages of 18-65,
  • Having a stroke history of 3- 36 months,
  • To be able to sit without support while both soles are in contact with the floor,
  • To be able to walk independently with or without using a walking aid,
  • To be able to understand and follow audio and visual warnings,
  • Scoring 24 points or more from the Mini-Mental State Exam.

Exclusion Criteria

  • Multiple stroke stories,
  • Hemorrhagic type stroke history,
  • Those with a history of falling in the past 1 year,
  • Those with a history of epilepsy,
  • Uncontrolled history of Hypertension and Diabetes

Outcomes

Primary Outcomes

Rivermead Mobility Index

Time Frame: Day 0 - Day 45

The Rivermead Mobility Index assesses functional mobility in gait, balance and transfers after stroke.

Timed Up and Go Test

Time Frame: Day 0 - Day 45

The Timed Up and Go (TUG) test is a performance-based measure of functional mobility that was initially developed to identify mobility and balance impairments in older adults.

2 Minute Walk Test

Time Frame: Day 0 - Day 45

2 Minute Walk Test (2MWT) is a measure of self-paced walking ability and functional capacity.

Berg Balance Scale

Time Frame: Day 0 - Day 45

The Berg balance scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function and takes approximately 20 minutes to complete.

Postural Assessment Scale for Stroke

Time Frame: Day 0 - Day 45

It measures the ability of an individual with stroke to maintain stable postures and equilibrium during positional changes. It consists of a 4-point scale where the items are scored from 0 to 3, and the total scoring ranges from 0 to 36

Barthel Index

Time Frame: Day 0 - Day 45

The Barthel Scale/Index (BI) is an ordinal scale used to measure performance in activities of daily living (ADL).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials